Autoantibody prevalence in chronic hepatitis B virus infection: Effect of interferon alfa

Hepatology

Volumn 24, Issue 3, 1996, Pages 520-523

  Gregorio, Germana V ^a   Jones, Huw ^a   Choudhuri, Kaushik ^a   Vegnente, Angela ^b   Bortolotti, Flavia ^c   Mieli Vergani, Giorgina ^a   Vergani, Diego ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAN1 INTERFERON; AUTOANTIBODY; PREDNISOLONE; STEROID;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; CHILD; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEROID THERAPY;

EID: 0029834605     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008781317     Document Type: Article

References (18)

1. Jacyna MR, Thomas HC. Pathogenesis and treatment of chronic infection. In: Zuckerman AJ, Thomas HC, eds. Viral hepatitis scientific basis and clinical management. New York: Churchill Livingstone, 1993:185-205.
2. Mayet WJ, Hess G, Gerken G, Rossol S, Voth R, Meyer zum Büschenfelde K-H. Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. HEPATOLOGY 1989; 10:24-28.
3. Fattovich G, Betterle C, Brollo L, Pedini B, Giustina G, Realdi G, Alberti A, et al. Autoantibodies during α-interferon therapy for chronic hepatitis B. J Med Virol 1991; 34:132-135.
4. Weber P, Wiedmann K-H, Klein R, Blum HE, Berg PA. Induction of autoimmune phenomenon in patients with chronic hepatitis B treated with gamma-interferon. J Hepatol 1994; 20:321-328.
5. Burman P, Karlsson FA, Öberg K, Alm G. Autoimmune thyroid disease in interferon-treated patients. Lancet 1985;ii:100-101.
6. Schultz M, Muller R, von zur Muhlen A, Brabant G. Induction of hyperthyroidism by interferon-α-2b. Lancet 1989;i:1452.
7. Fentiman IS, Thomas BS, Balkwill FR, Rubens RD, Hayward JL. Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet 1985;i:1166.
8. Talaymat A, Leventhal B, Sakarcan A, Kashima H, Monteiro C. Systemic lupus erythematosus in a child receiving long-term interferon therapy. J Pediatr 1992; 120:429-432.
9. Rönnblom LE, Alm GV, Öberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991; 151:178-183.
10. Akard LP, Hoffman R, Elias L, Saiers JH. Alpha interferon and immune haemolytic anaemia. Ann Intern Med 1986; 105:306.
11. Abdi EA, Venner PM. Immune thrombocytopaenia after α-interferon therapy in patients with cancer. JAMA 1986; 255:1878-1879.
12. Conlon KC, Urba WJ, Smith JW, Steis RG, Longo DL, Clark JW. Exacerbation of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990; 65:2237-2242.
13. Silva MO, Reddy KJ, Jeffers LJ, Hill M, Schiff ER. Interferon-induced chronic active hepatitis? Gastroenterology 1991; 101:840-842.
14. Fagan EA, Guarner PA, Perera SDK, Trowbridge R, Rolando N, Davison F, Williams R. Quantitation of hepatitis B virus DNA (HBV-DNA) in serum using the spot hybridization technique and scintillation counting. J Virol Methods 1985; 12:251-262.
15. Sternberg MJE. PROMOT: a FORTRAN program to scan protein sequences against a library of known motifs. Comput Appl Biosci 1991; 7: 257-260.
16. Kobayashi M, Koike K. Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organisation. Gene 1984; 30: 227-232.
17. Holborow J, Johnson G. Antinuclear factor in systemic lupus erythematosus. A consideration of the immunofiuorescent method of detecting antinuclear antibodies, with results obtained in a family study. Arthritis Rheum 1964; 7:119-127.
18. Oldstone MBA. Molecular mimicry and autoimmune disease. Cell 1987; 50:819-820.